Drugmaker Merck has submitted an application to the FDA for emergency use authorization of its antiviral COVID-19 pill.
manufacturers in India to provide molnupiravir to more than 100 low- and middle-income countries after approval from local regulatory agencies.
Merck: “Merck and Ridgeback Announce Submission of Emergency Use Authorization Application to the U.S.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Merck seeks FDA emergency use authorization for antiviral Covid-19 treatment molnupiravirMerck said it is seeking FDA emergency use authorization for its experimental antiviral Covid-19 treatment, molnupiravir.
Lire la suite »
Merck asks the FDA to authorize use of its promising COVID-19 pillDrugmaker Merck has asked U.S. regulators to authorize its promising pill protecting against COVID-19, setting the stage for a decision within weeks.
Lire la suite »
Merck asks FDA to authorize antiviral Covid pill for emergency useMerck has asked the FDA to authorize its antiviral Covid pill for emergency use. ScottGottliebMD weighs in: 'I think where the government misstepped is that we didn't invest enough in trying to scale up the manufacturing of therapeutics across the board.'
Lire la suite »
Merck Asks FDA To Authorize Promising Anti-COVID PillAn antiviral pill that people could take at home to speed recovery could prove groundbreaking, easing the crushing caseload on U.S. hospitals.
Lire la suite »
Merck asks FDA for emergency authorization for experimental Covid pillIf cleared by the Food and Drug Administration — a decision that could come in a matter of weeks — it would be the first pill shown to treat Covid-19.
Lire la suite »